Amneal Pharmaceuticals, Inc.

NYSE:AMRX

7.78 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Operating Activities:
Net Income 11.75716.787-81.678-93.34425.03329.683-10.094-5.858-2.39-240.081-6.46-20.459-6.09232.17614.545-6.962-22.033-23.944121.517-64.903-363.392-50.526-124.752-20.3317.465-250.0951.65262.19427.12237.44641.85353.898
Depreciation & Amortization 58.96155.57255.52856.93357.20657.11158.1561.05661.60859.69657.81561.18360.18656.48855.54959.87359.35958.07258.08354.30353.35850.70648.86847.49343.01332.14614.75112.84211.95810.53610.69.714
Deferred Income Tax 0009.883-2.076-0.0230000042.7954.04912.58814.05111.80944.8242.18623.130.033389.892-8.325-9.884-0.3285.882-14.481-0.5121.276-0.778000
Stock Based Compensation 7.1126.7246.7225.9746.6916.5617.5967.8317.6898.2628.0657.7427.7087.6325.335.1335.4155.6634.5395.0136.0956.2244.3473.6063.59160.4011.64400000
Change In Working Capital 68.691-56.717-11.97453.7-34.738-120.42954.281-135.2085.6718.93850.655-21.746-2.446-164.4455.03928.306-46.58118.469-161.513-73.898120.616-11.437-155.498155.781-29.249-88.403-31.119-18.716-2.276-5.76922.944-66.753
Accounts Receivables 21.812-100.67-55.73577.234-17.921-128.994195.97-113.28760.131-150.829124.268-34.51524.061-121.552108.38567.535-126.517136.662-60.893-86.269116.4972.058-165.012163.795-14.66-65.0324.981-13.21320.403-12.99941.064-64.48
Change In Inventory 0-23.247-12.2-23.09-42.566-38.018-22.508-11.07-25.931-39.846-25.54916.628-11.063-34.297-20.283-33.06-47.54-30.404-2.7785.513-6.248-5.478-14.1810.83317.947-24.066-47.589-6.64-14.2967.23-18.12-2.273
Change In Accounts Payables 059.85262.174-19.76133.07542.723-150.483-55.869-108.51322.724-48.777-11.113-11.68216.089-37.226-21.436.565-19.66734.8393.675-0.394-14.2330.695-28.354-42.157-0.02615.32512.5229.394000
Other Working Capital 46.8797.348-6.21319.317-7.3263.86-22.97945.01879.9800.7137.254-3.762-24.684.16315.261120.91231.878-132.6813.18310.7616.21622.9999.5079.6210.721-3.836-11.385-17.777000
Other Non Cash Items -4.747-1.84826.992102.67729.27115.75229.77948.88720.9933.21710.268-6.25418.9593.6233.6147.7993.79118.7953.2728.563-66.65934.452128.50973.42921.42861.848-2.2618.1863.871-21.98116.955-27.238
Operating Cash Flow 141.77439.657-4.41135.82381.387-11.345139.712-23.29293.57-125.521120.34363.26182.364-51.933148.128105.95844.776179.24149.026-50.889139.9121.094-108.41259.65162.129-98.57927.02965.26573.51326.00169.40836.374
Investing Activities:
Investments In Property Plant And Equipment -17.112-11.454-19.76-31.692-13.476-12.284-11.737-11.466-49.332-17.116-12.681-19.254-11.633-9.059-12.693-31.795-17.422-8.552-8.417-4.767-13.035-61.641-17.988-20.023-37.465-20.101-19.499-24.618-35.041-29.855-24.757-31.207
Acquisitions Net 0000000000-84.714-72.7150-73.828002.64-0.375-253.625-34.834038.312-3.4780-3.31-321.324015.7170000
Purchases Of Investments 00000000000000000000000000000000
Sales Maturities Of Investments 00000000000000000000000000000000
Other Investing Activites -3.64.239-9.7-25.9730-1.15-0.338-44.188-31.8-9-84.71450-74.328-0.917-1.10.44-0.375-254.67534.83443.017-11.688-3.47825.344-14.31-324.324015.717-19.500-4.856
Investing Cash Flow -20.712-6.465-19.76-31.692-13.476-12.284-11.737-11.466-49.332-16.116-97.395-86.969-11.633-82.887-12.693-31.795-14.782-8.927-262.042-4.76729.982-23.329-21.4665.321-40.775-341.425-19.499-8.901-35.041-29.855-24.757-36.063
Financing Activities:
Debt Repayment -87.21-26.996-15.377-262.57-63.944-14.907-72.659-17.654-42.60831.786-9.796-9.846-34.364-10.246-23.723-9.71-9.7-310.181172.579-7.313-7.591-6.997-7.369-106.81218.19635.475-3.60621.361-3.637-3.635-2.988-27.998
Common Stock Issued 00000000.6620000.8530000.3210001.40003.79700000000
Common Stock Repurchased -0.194-0.159-7.2122.0330-0.011-2.022-0.088-0.192-0.29-3.001-0.069-0.217-0.276-2.102-0.068-0.238-0.054-0.5030-0.005-0.9210154.83600000000
Dividends Paid 00000000000000000000000-182.9980-152.998-30-20-60-295.2650-30
Other Financing Activities -4.942-7.931-7.778161.738-22.4522.66261.781-4.513-3.332-8.537-51.774-20.504-8.974-27.822-2.426-1.572-5.1080.099295.40.015-0.005-2.078-14.495-112.10864.41-25.2360.36-0.865-0.137295.111-24.9649.022
Financing Cash Flow -92.346-35.086-23.155-100.832-86.585-12.256-12.9-22.167-46.13223.249-61.57-30.35-43.555-38.068-26.149-11.282-14.808-310.082467.979-7.298-7.596-9.075-21.864-218.9282.6457.241-33.2460.496-63.774-3.789-27.948-8.976
Other Information:
Effect Of Forex Changes On Cash 0.007-0.101-0.1650.201-0.301-0.6020.767-3.739-0.3970.025-1.5720.1780.290.227-0.5930.590.1921.115-0.86-1.282-2.261.589-0.2960.534-0.351-1.2640.411-0.292-5.1884.1581.08-0.734
Net Change In Cash 28.723-1.995-47.493.5-18.975-36.487115.842-60.664-2.291-118.363-40.194-53.8827.466-172.661108.69363.47115.378-138.653254.103-64.236160.036-9.721-152.03646.586103.60315.973-25.30556.568-30.49-3.48527.962-9.399
Cash At End Of Period 78.34549.62251.61799.10795.607114.582151.06935.22795.89198.182216.545256.739310.619283.153455.814347.121283.65268.272406.925152.822217.05857.02266.743218.779172.19368.5952.61777.92221.35451.84455.32927.367